Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05733351
Title Vudalimab in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer
Recruitment Suspended
Gender male
Phase Phase I
Variant Requirements No
Sponsors Emory University
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.